These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9607536)

  • 21. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
    Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
    Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute renal failure as a complication of transarterial chemoembolization in a patient with hepatocellular carcinoma].
    La Spada E; La Spada M; Brusca T; Campagna ME; Di Gesaro V; Terranova A; Sandonato L; Soresi M
    Recenti Prog Med; 2007 Apr; 98(4):232-5. PubMed ID: 17547360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic resection for bilobar hepatocellular carcinoma: is it justified?
    Liu CL; Fan ST; Lo CM; Ng IO; Poon RT; Wong J
    Arch Surg; 2003 Jan; 138(1):100-4. PubMed ID: 12511161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
    J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.
    Jang JW; Choi JY; Bae SH; Kim CW; Yoon SK; Cho SH; Yang JM; Ahn BM; Lee CD; Lee YS; Chung KW; Sun HS
    J Hepatol; 2004 Sep; 41(3):427-35. PubMed ID: 15336446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management.
    Poon RT; Fan ST; Lo CM; Liu CL; Ngan H; Ng IO; Wong J
    Am J Gastroenterol; 1999 Sep; 94(9):2460-6. PubMed ID: 10484009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.
    Lee SG; Hwang S; Jung JP; Lee YJ; Kim KH; Ahn CS
    Br J Surg; 2007 Mar; 94(3):320-6. PubMed ID: 17205495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
    Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous tumor rupture and surgical prognosis of patients with hepatocellular carcinoma.
    Zhang XF; Wei T; Liu XM; Lv Y
    Scand J Gastroenterol; 2012 Sep; 47(8-9):968-74. PubMed ID: 22631224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma : treated with hepatic arterial embolization, an analysis of prognostic features in 150 cases.
    Eurvilaichit C; Kanjanapitak A
    J Med Assoc Thai; 2000 Sep; 83(9):983-91. PubMed ID: 11075962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
    Kim MH; Choi MS; Choi YS; Kim DY; Lee JM; Paik SW; Lee JH; Koh KC; Yoo BC; Choi D; Rhee JC
    Korean J Hepatol; 2006 Mar; 12(1):55-64. PubMed ID: 16565606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.
    Malagari K; Chatzimichael K; Alexopoulou E; Kelekis A; Hall B; Dourakis S; Delis S; Gouliamos A; Kelekis D
    Cardiovasc Intervent Radiol; 2008; 31(2):269-80. PubMed ID: 17999110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodality management of hepatocellular carcinoma larger than 10 cm.
    Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
    J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.
    Zeng ZC; Fan J; Tang ZY; Zhou J; Qin LX; Wang JH; Sun HC; Wang BL; Zhang JY; Jiang GL; Wang YQ
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):432-43. PubMed ID: 15667964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization.
    Shen H; Agarwal D; Qi R; Chalasani N; Liangpunsakul S; Lumeng L; Yoo H; Kwo P
    Aliment Pharmacol Ther; 2007 Aug; 26(3):393-400. PubMed ID: 17635374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of spontaneous bleeding due to hepatocellular carcinoma.
    Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N
    Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of laparoscopy on postoperative recurrence and survival in patients with ruptured hepatocellular carcinoma undergoing hepatic resection.
    Lang BH; Poon RT; Fan ST; Wong J
    Br J Surg; 2004 Apr; 91(4):444-9. PubMed ID: 15048744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
    Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
    Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.